By Professor Peter Gunning

Conference Posters

Hardeman EC; Kee AJ; Lucas CA; Chagan J; Gunning PW, 2016, 'Metabolic impact of targeting the tropomyosin/actin cytoskeleton to treat cancer', CA, San Francisco, Vol. 27, presented at Annual Meeting of the American-Society-for-Cell-Biology (ASCB), CA, San Francisco, 03 December 2016 - 07 December 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000396046900905&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stehn J; Mariana A; Failes T; Ashokakumar V; Eiffe E; Heaton A; Hook J; Sivanandhan D; Arndt G; Gunning P; Brown D, 2016, 'Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC)', GERMANY, Munich, Vol. 69, pp. S116 - S116, presented at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, GERMANY, Munich, 29 November 2016 - 02 December 2016, http://dx.doi.org/10.1016/S0959-8049(16)32946-X

Jalilian I; Oldfield R; Gunning PW; Knothe Tate , 2016, 'Live Multiplexed Imaging of Stem Cell Mechanotransduction and Mechanoadaptation', Orlando, FL, U.S.A., Vol. 41, pp. 0713 - 0713, presented at Orthopaedic Research Society, Orlando, FL, U.S.A., 05 March 2016 - 08 March 2016

Chisholm OT; Parisio M; Heaton A; Brown D; Gunning P, (eds.), 2015, 'Blended strategies for learning about medicines development', UNSW, pp. 74 - 75, presented at UNSW Learning and Teaching Forum - Blended Learning: Past, Present and Future, UNSW, 16 October 2015 - 16 October 2015

Suchowerska A; Chen B; Mueller J; Ittner A; Hardeman E; Ittner L; Janitz M; Gunning P; Fath T, 2013, 'Increased levels of actin filaments containing the tropomyosin Tm5NM1 regulate excitotoxicity in the mouse', Vol. 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209348705376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page